Skip to main content

Pantothenate Kinase-Associated Neurodegeneration clinical trials at UCSF
1 in progress, 0 open to new patients

  • Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration

    Sorry, in progress, not accepting new patients

    Patients with PKAN will be treated with the iron chelator deferiprone for 18 months. Only patients who have completed the earlier study TIRCON2012V1 (a double-blind placebo-controlled trial in which participants were randomized to receive either deferiprone or placebo for 18 months) are eligible to enroll.

    Oakland, California and other locations